DEKON AGR (02419) reports a significant increase in profit before fair value adjustment of biological assets in the midterm, expected to be around 1.1 to 1.4 billion yuan compared to the same period last year.

DEKON AGR (02419) announces that the group expects to achieve a profit before fair value adjustment of biological assets of approximately RMB 1.1 billion to RMB 1.4 billion for the six months ending on June 30, 2025, compared to a profit before fair value adjustment of biological assets of approximately RMB 363 million for the same period in 2024. The expected increase in profit is mainly attributed to the company's improved management efficiency, further scale effects, and continued decrease in pig production costs.